Cargando…

New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I–Interacting Kinase (TNNi3K)

We report the synthesis of several related 4-anilinoquinazolines as inhibitors of cardiac troponin I–interacting kinase (TNNi3K). These close structural analogs of 3-((6,7-dimethoxyquinazolin-4-yl)amino)-4-(dimethylamino)-N-methylbenzenesulfonamide (GSK114) provide new understanding of structure–act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asquith, Christopher R. M., Laitinen, Tuomo, Wells, Carrow I., Tizzard, Graham J., Zuercher, William J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180948/ https://www.ncbi.nlm.nih.gov/pubmed/32272798 http://dx.doi.org/10.3390/molecules25071697

Ejemplares similares

TNNI3K is a novel mediator of myofilament function and phosphorylates cardiac troponin I
por: Wang, Hui, et al.
Publicado: (2013)

Anilinoquinazoline inhibitors of the RET kinase domain—Elaboration of the 7-position
por: Jordan, Allan M., et al.
Publicado: (2016)

TNNI3K, a Cardiac-Specific Kinase, Promotes Physiological Cardiac Hypertrophy in Transgenic Mice
por: Wang, Xiaojian, et al.
Publicado: (2013)

Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK)
por: Asquith, Christopher R. M., et al.
Publicado: (2019)

A case report of recessive restrictive cardiomyopathy caused by a novel mutation in cardiac troponin I (TNNI3)
por: Pantou, Malena P., et al.
Publicado: (2019)

The Diverse Roles of TNNI3K in Cardiac Disease and Potential for Treatment
por: Pham, Caroline, et al.
Publicado: (2021)

Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy
por: van den Wijngaard, A., et al.
Publicado: (2011)

Identification of a nonsense mutation in TNNI3K associated with cardiac conduction disease
por: Liu, Jiang, et al.
Publicado: (2020)

Tnni3k Modifies Disease Progression in Murine Models of Cardiomyopathy
por: Wheeler, Ferrin C., et al.
Publicado: (2009)

Discovery of Potent EGFR Inhibitors With 6-Arylureido-4-anilinoquinazoline Derivatives
por: Li, Meng, et al.
Publicado: (2021)

Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency
por: Gan, Peiheng, et al.
Publicado: (2019)

Optimization of Substituted 6-Salicyl-4-Anilinoquinazoline Derivatives as Dual EGFR/HER2 Tyrosine Kinase Inhibitors
por: Li, Dong-Dong, et al.
Publicado: (2013)

High prevalence of Arginine to Glutamine Substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians
por: Rani, Deepa Selvi, et al.
Publicado: (2012)

Potent Cardioprotective Effect of the 4-Anilinoquinazoline Derivative PD153035: Involvement of Mitochondrial K(ATP) Channel Activation
por: Cavalheiro, Renata A., et al.
Publicado: (2010)

Genetic Burden of TNNI3K in Diagnostic Testing of Patients With Dilated Cardiomyopathy and Supraventricular Arrhythmias
por: Pham, Caroline, et al.
Publicado: (2023)

Expression Levels of the Tnni3k Gene in the Heart Are Highly Associated with Cardiac and Glucose Metabolism-Related Phenotypes and Functional Pathways
por: Gu, Qingqing, et al.
Publicado: (2023)

TNNI1 Mutated in Autosomal Dominant Proximal Arthrogryposis
por: Nishimori, Yukako, et al.
Publicado: (2021)

1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors
por: Asquith, Christopher R. M., et al.
Publicado: (2018)

Dissection of a Quantitative Trait Locus for PR Interval Duration Identifies Tnni3k as a Novel Modulator of Cardiac Conduction
por: Lodder, Elisabeth M., et al.
Publicado: (2012)

A Novel Missense Mutation in TNNI3K Causes Recessively Inherited Cardiac Conduction Disease in a Consanguineous Pakistani Family
por: Ramzan, Shafaq, et al.
Publicado: (2021)

Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives
por: Nasab, Rezvan Rezaee, et al.
Publicado: (2017)

Tnni1b-ECR183-d2, an 87 bp cardiac enhancer of zebrafish
por: Zhang, Yawen, et al.
Publicado: (2020)

Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors
por: Elsayed, Zainab M., et al.
Publicado: (2023)

De Novo Missense Mutations in TNNC1 and TNNI3 Causing Severe Infantile Cardiomyopathy Affect Myofilament Structure and Function and Are Modulated by Troponin Targeting Agents
por: Hassoun, Roua, et al.
Publicado: (2021)

Effects of Intermittent Exercise on Cardiac Troponin I and Creatine Kinase-MB
por: Rahnama, Nader, et al.
Publicado: (2011)

Distal arthrogryposis with variable clinical expression caused by TNNI2 mutation
por: Čulić, Vida, et al.
Publicado: (2016)

3-(2-Aminoethyl)-2-anilinoquinazolin-4(3H)-one methanol hemisolvate
por: Gao, Tao, et al.
Publicado: (2009)

MIP-2A Is a Novel Target of an Anilinoquinazoline Derivative for Inhibition of Tumour Cell Proliferation
por: Tokunaga, Mayuko, et al.
Publicado: (2013)

NAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivatives
por: Ghorab, Mostafa M, et al.
Publicado: (2016)

HIRA Is Required for Heart Development and Directly Regulates Tnni2 and Tnnt3
por: Dilg, Daniel, et al.
Publicado: (2016)

Dephosphorylation specificities of protein phosphatase for cardiac troponin I, troponin T, and sites within troponin T
por: Jideama, Nathan M., et al.
Publicado: (2006)

Pediatric restrictive cardiomyopathy due to a heterozygous mutation of the TNNI3 gene
por: Chen, Yan, et al.
Publicado: (2014)

Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET
por: Pantaleo, Maria A., et al.
Publicado: (2010)

Anticancer activity of pyrimidodiazepines based on 2-chloro-4-anilinoquinazoline: synthesis, DNA binding and molecular docking
por: Cuartas, Viviana, et al.
Publicado: (2021)

Efficient N-arylation of 4-chloroquinazolines en route to novel 4-anilinoquinazolines as potential anticancer agents
por: Nishimura, Rodolfo H V, et al.
Publicado: (2021)

New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors
por: Byrne, Dominic P., et al.
Publicado: (2018)

4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies
por: Nada, Hossam, et al.
Publicado: (2022)

Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes
por: Matossian, Margarite D., et al.
Publicado: (2017)

Cardiac Troponin I as Compared to Troponin T for the Detection of Myocardial Damage in Horses
por: Van Der Vekens, N., et al.
Publicado: (2015)

Whole-Exome Sequencing Identifies a Novel Variant (c.1538T > C) of TNNI3K in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Xie, Ting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v2v0nrkbru1rgtkimrbo6jirgm